Zhejiang Yatai Pharmaceutical Co., Ltd. (SHE:002370)
China · Delayed Price · Currency is CNY 7.11
-0.03 (-0.42%)
Feb 4, 2026, 3:04 PM CST
SHE:002370 Revenue
Zhejiang Yatai Pharmaceutical had revenue of 76.23M CNY in the quarter ending September 30, 2025, a decrease of -10.21%. This brings the company's revenue in the last twelve months to 326.64M, down -23.25% year-over-year. In the year 2024, Zhejiang Yatai Pharmaceutical had annual revenue of 405.17M, down -3.68%.
Revenue (ttm)
326.64M
Revenue Growth
-23.25%
P/S Ratio
16.30
Revenue / Employee
617.48K
Employees
529
Market Cap
5.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 405.17M | -15.47M | -3.68% |
| Dec 31, 2023 | 420.64M | 47.20M | 12.64% |
| Jan 1, 2023 | 373.44M | 58.31M | 18.50% |
| Jan 1, 2022 | 315.13M | -199.75M | -38.80% |
| Dec 31, 2020 | 514.89M | -193.10M | -27.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 3.63B |
| Jianmin Pharmaceutical Group | 3.18B |
| Jiangsu Lianhuan Pharmaceutical | 2.60B |
| Luoxin Pharmaceuticals Group Stock | 2.49B |
| Fuan Pharmaceutical (Group) | 1.71B |
| Hunan Fangsheng Pharmaceutical | 1.68B |
| Bide Pharmatech | 1.27B |
| Nanjing Hicin Pharmaceutical | 615.39M |